PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroder Real Regulatory News (SREI)

Share Price Information for Schroder Real (SREI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 44.90
Bid: 44.60
Ask: 45.30
Change: -0.10 (-0.22%)
Spread: 0.70 (1.57%)
Open: 44.70
High: 45.60
Low: 44.70
Prev. Close: 45.00
SREI Live PriceLast checked at -
Schroder Real Estate is an Investment Trust

To provide the shareholders with an attractive level of income, together with the potential for income and capital growth, from investing in a diversified portfolio of UK commercial real estate.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Invista Foundation Property Trust

27 Oct 2011 14:29

RNS Number : 9788Q
Cazenove Capital Management Ltd
27 October 2011
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

Cazenove Capital Management Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Invista Foundation Property Trust Limited

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

26/10/11

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

Yes - Picton Property Income Limited

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ord NPV

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

16,358,403

4.60

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

16,358,403

4.60

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary NPV

Sale

3,435

0.36/GBP

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27/10/11

 

Contact name:

Laura Whelan

Telephone number:

0203 479 0461

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETLLFFVITLDFIL
Date   Source Headline
29th Apr 20247:00 amRNSNotice of Results
13th Mar 20244:44 pmRNSHolding(s) in Company
8th Mar 20245:01 pmRNSHolding(s) in Company
6th Mar 20245:46 pmRNSHolding(s) in Company
6th Mar 20245:42 pmRNSHolding(s) in Company
29th Feb 20242:13 pmRNSInvestor Presentation
27th Feb 20247:00 amRNSNAV and Dividend for Quarter to 31 December 2023
26th Jan 20245:02 pmRNSQuotedData's Weekly News & Interview
26th Jan 20244:23 pmRNSQuotedData's Weekly News & Interview
15th Dec 20231:03 pmRNSResult of EGM
11th Dec 202312:13 pmRNSHolding(s) in Company
21st Nov 20238:35 amRNSWebinar details
21st Nov 20237:01 amRNSDividend Announcement for the Quarter to 30 Sep 23
21st Nov 20237:00 amRNSInterim Results for the period ended 30 Sept 2023
21st Nov 20237:00 amRNSPublication of circular and notice of EGM
1st Nov 20237:00 amRNSNon-Executive Director Change
18th Oct 20234:08 pmRNSInvestor Presentation
27th Sep 20234:54 pmRNSResult of AGM
26th Sep 20234:47 pmRNSHolding(s) in Company
22nd Sep 20237:00 amRNSNotice of Results
8th Sep 202311:21 amRNSHolding(s) in Company
27th Jul 20232:43 pmRNSAnnual Report for year ended 31 March 2023
27th Jul 20232:11 pmRNSInvestor Presentation
27th Jul 20237:00 amRNSNAV and Dividend for the Quarter to 30 June 2023
8th Jun 20236:26 pmRNSDividend PID Status
8th Jun 202311:29 amRNSHolding(s) in Company
8th Jun 20237:01 amRNSDividend Declaration
8th Jun 20237:00 amRNSFull Year Results for the year ended 31 March 2023
2nd Jun 202311:18 amRNSInvestor Presentation
2nd May 20239:00 amRNSNotice of Full Year Results
20th Apr 202310:12 amRNSDirector Declaration
10th Mar 20232:12 pmRNSDirector/PDMR Shareholding
1st Mar 20234:34 pmRNSHolding(s) in Company
3rd Feb 20234:13 pmRNSInvestor Presentation
3rd Feb 20237:00 amRNSNAV and Dividend for the quarter to 30 Dec 2022
12th Dec 20227:00 amRNSKepler Trust Intelligence: New Research
1st Dec 20224:41 pmRNSHolding(s) in Company
16th Nov 20227:01 amRNSDividend Declaration
16th Nov 20227:01 amRNSDirectorate Change
16th Nov 20227:00 amRNSInterim results for the period ended 30 September
19th Oct 20227:00 amRNSInvestor Presentation
12th Oct 20227:00 amRNSNotice of Half Year Results
30th Sep 20224:53 pmRNSTotal Voting Rights
21st Sep 20224:10 pmRNSResult of AGM
15th Sep 20225:34 pmRNSTransaction in Own Shares
14th Sep 20225:18 pmRNSTransaction in Own Shares
13th Sep 20225:21 pmRNSTransaction in Own Shares
12th Sep 20225:33 pmRNSTransaction in Own Shares
9th Sep 20225:33 pmRNSTransaction in Own Shares
8th Sep 20225:29 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.